FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3012010046> ?p ?o ?g. }

• W3012010046 endingPage "40" @default.
• W3012010046 startingPage "29" @default.
• W3012010046 abstract "Introduction: Preeclampsia remains one of the most common causes of maternal and perinatal mortality worldwide. A significant role in the pathogenesis of this pathology is assigned to placental ischemia and endothelial dysfunction. Therefore, the aim of the present study was to study the effectiveness of asialized erythropoietin and arginase II selec­tive inhibitors: KUD-259 and KUD-974 in the correction of morphofunctional disorders of the cardiovascular system in experimental preeclampsia.&#x0D; Materials and methods: The study was performed in 260 female Wistar rats, each weighing 250–300 g. An AD­MA-like preeclampsia was reproduced in the experiment. To assess the emerging morphofunctional disorders, the fol­lowing parameters were used: blood pressure, coefficient of endothelial dysfunction, microcirculation in the placenta, proteinuria, fluid content in the omentum, concentration of terminal metabolites in the blood plasma, and morphometric parameters of fetuses.&#x0D; Results and discussion: The administration of arginase II selective inhibitor KUD-974 in combination with asialized erythropoietin leads to a pronounced correction of emerging changes: a decrease in systolic and diastolic blood pres­sure in 1.5 and 1.7 times, a decrease in proteinuria in 3.6 times and a decrease in fluid content in the omentum. When arginase II selective inhibitor KUD 974 and asialized erythropoietin are used with methyldopa, the positive effects of the former are enhanced.&#x0D; Conclusion: Arginase II selective inhibitors KUD-259 and KUD-974 and asialized erythropoietin have a pronounced positive effect on the correction of morphofunctional disorders in animals with ADMA-like preeclampsia." @default.
• W3012010046 created "2020-03-23" @default.
• W3012010046 creator A5010306328 @default.
• W3012010046 creator A5014803659 @default.
• W3012010046 creator A5019287946 @default.
• W3012010046 creator A5026103892 @default.
• W3012010046 creator A5037110251 @default.
• W3012010046 creator A5060562426 @default.
• W3012010046 creator A5080691324 @default.
• W3012010046 creator A5081035964 @default.
• W3012010046 creator A5082334411 @default.
• W3012010046 date "2020-03-20" @default.
• W3012010046 modified "2023-10-17" @default.
• W3012010046 title "Correction of morphofunctional disorders of the cardiovascular system with asialized erythropoietin and arginase II selective inhibitors KUD 974 and KUD 259 in experimental preeclampsia" @default.
• W3012010046 cites W1993610142 @default.
• W3012010046 cites W2006364933 @default.
• W3012010046 cites W2025423547 @default.
• W3012010046 cites W2028326426 @default.
• W3012010046 cites W2046288606 @default.
• W3012010046 cites W2050154517 @default.
• W3012010046 cites W2092155853 @default.
• W3012010046 cites W2095567962 @default.
• W3012010046 cites W2125717298 @default.
• W3012010046 cites W2146533887 @default.
• W3012010046 cites W2157225770 @default.
• W3012010046 cites W2175954218 @default.
• W3012010046 cites W2336953894 @default.
• W3012010046 cites W2341753104 @default.
• W3012010046 cites W2510089156 @default.
• W3012010046 cites W2548103122 @default.
• W3012010046 cites W2611530541 @default.
• W3012010046 cites W2745300693 @default.
• W3012010046 cites W2748509384 @default.
• W3012010046 cites W2753612746 @default.
• W3012010046 cites W2804692877 @default.
• W3012010046 cites W2850708907 @default.
• W3012010046 cites W2899665580 @default.
• W3012010046 cites W2936893544 @default.
• W3012010046 cites W2954851922 @default.
• W3012010046 cites W2970423612 @default.
• W3012010046 cites W2977481512 @default.
• W3012010046 cites W2997799856 @default.
• W3012010046 cites W2997880932 @default.
• W3012010046 cites W2998894809 @default.
• W3012010046 doi "https://doi.org/10.3897/rrpharmacology.6.50851" @default.
• W3012010046 hasPublicationYear "2020" @default.
• W3012010046 type Work @default.
• W3012010046 sameAs 3012010046 @default.
• W3012010046 citedByCount "4" @default.
• W3012010046 countsByYear W30120100462020 @default.
• W3012010046 countsByYear W30120100462021 @default.
• W3012010046 crossrefType "journal-article" @default.
• W3012010046 hasAuthorship W3012010046A5010306328 @default.
• W3012010046 hasAuthorship W3012010046A5014803659 @default.
• W3012010046 hasAuthorship W3012010046A5019287946 @default.
• W3012010046 hasAuthorship W3012010046A5026103892 @default.
• W3012010046 hasAuthorship W3012010046A5037110251 @default.
• W3012010046 hasAuthorship W3012010046A5060562426 @default.
• W3012010046 hasAuthorship W3012010046A5080691324 @default.
• W3012010046 hasAuthorship W3012010046A5081035964 @default.
• W3012010046 hasAuthorship W3012010046A5082334411 @default.
• W3012010046 hasBestOaLocation W30120100461 @default.
• W3012010046 hasConcept C126322002 @default.
• W3012010046 hasConcept C164007495 @default.
• W3012010046 hasConcept C185592680 @default.
• W3012010046 hasConcept C2777218350 @default.
• W3012010046 hasConcept C2777468819 @default.
• W3012010046 hasConcept C2778534260 @default.
• W3012010046 hasConcept C2779234561 @default.
• W3012010046 hasConcept C515207424 @default.
• W3012010046 hasConcept C54355233 @default.
• W3012010046 hasConcept C55493867 @default.
• W3012010046 hasConcept C71924100 @default.
• W3012010046 hasConcept C86803240 @default.
• W3012010046 hasConceptScore W3012010046C126322002 @default.
• W3012010046 hasConceptScore W3012010046C164007495 @default.
• W3012010046 hasConceptScore W3012010046C185592680 @default.
• W3012010046 hasConceptScore W3012010046C2777218350 @default.
• W3012010046 hasConceptScore W3012010046C2777468819 @default.
• W3012010046 hasConceptScore W3012010046C2778534260 @default.
• W3012010046 hasConceptScore W3012010046C2779234561 @default.
• W3012010046 hasConceptScore W3012010046C515207424 @default.
• W3012010046 hasConceptScore W3012010046C54355233 @default.
• W3012010046 hasConceptScore W3012010046C55493867 @default.
• W3012010046 hasConceptScore W3012010046C71924100 @default.
• W3012010046 hasConceptScore W3012010046C86803240 @default.
• W3012010046 hasIssue "1" @default.
• W3012010046 hasLocation W30120100461 @default.
• W3012010046 hasLocation W30120100462 @default.
• W3012010046 hasLocation W30120100463 @default.
• W3012010046 hasLocation W30120100464 @default.
• W3012010046 hasLocation W30120100465 @default.
• W3012010046 hasOpenAccess W3012010046 @default.
• W3012010046 hasPrimaryLocation W30120100461 @default.
• W3012010046 hasRelatedWork W2016126087 @default.
• W3012010046 hasRelatedWork W2101858601 @default.
• W3012010046 hasRelatedWork W2103119396 @default.
• W3012010046 hasRelatedWork W2129577681 @default.

• next